The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted the public to the circulation of an unregistered Gold Vision Oxytocin injection 10IU, bearing a fake NAFDAC registration number, A4-9566.
The alert, published on the agency’s website on Monday, states that the product is purportedly manufactured by Anhui Hongye Pharmaceutical Co., Ltd., Fengyang East Road, Bengbu, Anhui Province, China, and marketed by Gold Vision Medicals, No.4 Range Avenue, Independence Layout, Enugu, Nigeria.
According to NAFDAC, the product was discovered during a Risk-Based sampling survey activity conducted by officers of ... Marketing Surveillance (PMS) directorate of NAFDAC.
“Further investigation revealed that three (3) falsified products, namely A-tocin injection, Extocin Injection, and Claxitodin injection, were discovered during the 2023 RBPMS sampling, “the agency said.
NAFDAC confirmed that all the products were said to have been manufactured by the same manufacturer, and all the products bear the same falsified NAFDAC Reg. No. A4-9566.
“It is essential to highlight that these products identified in this alert are confirmed as falsified because they are not present in the NAFDAC-registered products database,” the statement added.
Oxytocin is a naturally occurring hormone and neuropeptide, also available as a pharmaceutical drug, primarily used to induce or strengthen labor, control postpartum bleeding, and support lactation.
It binds to oxytocin receptors on the smooth muscle of the uterus, activating a G-protein-coupled receptor pathway. This leads to increased intracellular calcium levels, causing uterine contractions.
NAFDAC warned that using unregistered or falsified Oxytocin injections poses serious health risks to both mothers and newborns.
“These products may contain incorrect doses, no active ingredient, or harmful contaminants, leading to ineffective uterine contractions, postpartum hemorrhage (PPH), and even maternal death, “the agency said.
The regulator also cautioned that poor-quality oxytocin may also delay or fail to stop bleeding after childbirth, increasing the need for emergency interventions like blood transfusions or surgery.
The details of the falsified products are as follows:
All NAFDAC zonal directors and state coordinators have been instructed to conduct surveillance and retrieve any of the falsified products if found within their zones and states in Nigeria.
The agency also called on importers, distributors, retailers, healthcare professionals, and consumers are hereby advised to exercise caution and vigilance within the supply chain to avoid the importation, distribution, sale, and use of unregistered /falsified Oxytocin Injection.
NAFDAC advised that all medicinal products and medical devices must be obtained from authorized/licensed suppliers. The products’ authenticity and physical condition should be carefully checked.
NAFDAC advised that all medicinal products and medical devices must be obtained from authorized/licensed suppliers. The products’ authenticity and physical condition should be carefully checked.
Healthcare professionals and consumers are advised to report any suspicion of the sale of substandard and falsified medicines or medical devices to the nearest NAFDAC office, NAFDAC on 0800-162-3322, or via email: [email protected]
Similarly, healthcare professionals and patients are also encouraged to report adverse events or side effects related to the use of medicinal products or devices to the nearest NAFDAC office, or through the use of the E-reporting platforms available on the NAFDAC website www.nafdac.gov.ng or via the Med- safety application available for download on android and IOS stores or via e-mail on [email protected]